Effect of Selective Cyclooxygenase 2 Inhibitor in TCDD Pre-exposed Thyroid Papillary Carcinoma Cell Line

김해성; 안광성; 이정현; Chae Yang Seok; 원남희; Jongsang Choi; Chul Hwan Kim

Effect of Selective Cyclooxygenase 2 Inhibitor in TCDD Pre-exposed Thyroid Papillary Carcinoma Cell Line

Recommendations

Search

TCDD에 노출된 갑상샘 유두암종 세포주에서 선택적 Cyclooxygenase 2 억제제의 효과

Type: Academic journal

Author: 김해성 안광성 이정현 Chae Yang Seok 원남희 Jongsang Choi Chul Hwan Kim

Journal: 대한병리학회 Journal of Pathology and Translational Medicine Journal of Pathology and Translational Medicine 제45권 제1호 KCI Accredited Journals

Published: 2011.1

Pages: 1 - 8 (8page)

Usage

Effect of Selective Cyclooxygenase 2 Inhibitor in TCDD Pre-exposed Thyroid Papillary Carcinoma Cell Line

Abstract· Keywords

Report Errors

Background: Cyclooxygenase 2 (COX-2) is related to carcinogenesis and progression of cancer. COX-2 has been detected in thyroid cancer. This suggests that COX-2 inhibitor may be useful to control the growth of thyroid cancer cells as well as the progression of thyroid cancer. Tetrachlorodibenzodioxin (TCDD), acting as an inflammatory cytokine, directly induces the expression of COX-2. We examine whether TCDD controls the effect of COX-2 inhibitor on thyroid cancer cells. Methods: The effects of TCDD and celecoxib on thyroid papillary carcinoma cell line (SNU790) were examined using cell proliferation and fluorescence-activated cell sorting analysis. Western blot analysis was performed to determine the expressed COX-2 levels and the cell cycle-related proteins. The matrix metalloproteinase-2 (MMP-2) expression and gelatinolytic activity were examined using real time-polymerase chain reaction and zymography. Results: TCDD directly induced the growth of SNU790 and the expression of cyclin D1, cyclin A, cyclin E, p21 and COX-2. Celecoxib suppressed the growth of SNU790 and the expression of cyclin D1 and cyclin E. Celecoxib reduced the MMP-2 expression and the gelatinolytic activity, but those effects were decreased in the SNU790 by either pre-treatment with TCDD or co-treatment with TCDD and celecoxib. Conclusions: Celocoxib effect is directly reduced depending on the exposure to TCDD. TCDD exposure should be considered in the treatment with Celecoxib.

#Cyclooxygenase 2 #Cyclooxygenase 2 inhibitors #Tetrachlorodibenzodioxin #Carcinoma #papillary #Thyroid gland

No content found

References (26)

Add References

Agoff SN / 2000 / The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia / Am J Pathol 157 : 737 ~ 745

Berg J / 20

Cornetta AJ / 2002 / Cyclooxygenase- 2 expression in human thyroid carcinoma and Hashimoto’s thyroiditis / Laryngoscope 112 : 238 ~ 242

Dannenberg AJ / 2001 / Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer / Lancet Oncol 2 : 544 ~ 551

Eberhart CE / 1994 / Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas / Gastroenterology 107 : 1183 ~ 1188